Last Posted: Sep 03, 2021
- COVID-19 and Sickle Cell Disease: Frequently Asked Questions
American Society for Hematology, 2021
- Association of KLOTHO polymorphisms with clinical complications of sickle cell anemia.
Batista Jéssica V G F, et al. Annals of hematology 2021 6
- Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.
Figueiredo Camylla Vilas Boas, et al. PloS one 2021 0 (2) e0246067
- Using Artificial Intelligence to Predict Surgical Shunts in Men with Ischemic Priapism.
Masterson Thomas A et al. The Journal of urology 2020 Jun 101097JU0000000000001183
- Clinical and Genetic Predictors of Priapism in Sickle Cell Disease: Results from the Recipient Epidemiology and Donor Evaluation Study III Brazil Cohort Study.
Cintho Ozahata Mina, et al. The journal of sexual medicine 2019 10
- Association between MTHFR 677C>T polymorphism and vascular complications in sickle cell disease: A meta-analysis.
Lakkakula B V K S, et al. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019 1
- Self-management recommendations for sickle cell disease: A Ghanaian health professionals' perspective.
Druye Andrews et al. Health science reports 2018 Nov 1(11) e88
- MANAGEMENT OF PATIENTS WITH SICKLE CELL DISEASE IN ORAL SURGERY: Literature Review and Update.
Prevost Raphaelle et al. Journal of stomatology, oral and maxillofacial surgery 2018 Jun
- Genome-wide association study of erythrocyte density in sickle cell disease patients.
Ilboudo Yann, et al. Blood cells, molecules & diseases 2017 6 60-65
- Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
Ataga Kenneth I et al. The New England journal of medicine 2017 Feb 376(5) 429-439
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.